Skip to content

Attachment, Patient Self-disclosure and Psychotherapy Outcome

Attachment as a Moderator of the Relationship Between Patient Self-disclosure and Psychotherapy Outcome: Separating Within- From Between-patient Effects

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05151354
Enrollment
1500
Registered
2021-12-09
Start date
2015-01-01
Completion date
2021-09-01
Last updated
2021-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attachment, Psychotherapy, Self Disclosure, Treatment Outcome

Brief summary

This study investigates whether within- and between-patient effects of attachment moderate the association between self-disclosure and psychotherapy outcome.

Detailed description

Participants are recruited at the University Clinic Heidelberg at the beginning of their (usually) 8-week inpatient treatment. After informed consent, patients routinely fill out weekly questionnaires on attachment, self-disclosure, and symptom severity. This study is the first to disentangle stable, trait-like (between-person) effects of both attachment and self-disclosure from within-person changes over the course of treatment. The study investigates whether (changes in) attachment moderate the association between (changes in) self-disclosure and psychotherapy outcome.

Interventions

OTHERPsychotherapy

Patients receive 8 weeks of inpatient psychotherapeutic treatment. Treatment consists of individual and group psychodynamic psychotherapy, as well as an individual combination of art, music, body-oriented and relaxation therapies, which are also carried out in group settings. Treatments is provided by an interdisciplinary team of psychotherapists with a medical or psychology degree, art of music therapists, social workers, physiotherapists and specialist nurses.

Sponsors

University Hospital Heidelberg
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients of at least 18 years of age * treated at the inpatient unit of a hospital for psychosomatic medicine * provided measurements of symptoms, attachment style, and self-disclosure for at least one measurement occasion

Exclusion criteria

* bipolar, acute psychotic or substance abuse disorders

Design outcomes

Primary

MeasureTime frameDescription
Symptom Checklist Short Form (SCL-K11)for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)Symptom measure

Secondary

MeasureTime frameDescription
Inpatient and day clinic experiences questionnaire (IDES)for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)measure of self-disclosure and other treatment factors
Relationship Questionnaire 2 (RQ-2)for each participant: weekly assessment for 8 weeks of inpatient psychotherapy. Data will be reported for 7 years of continous study enrollment (2014 - 2021)Attachment measure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026